« Glucagon-Like Peptide-1 Receptor Agonist Treatment in Type 1 Diabetes: A Review of Current Evidence and Rationale for Use ». Canadian Diabetes & Endocrinology Today 1, no. 3 (octobre 12, 2023): 21–26. Consulté le mars 29, 2026. https://CanadianDiabetesAndEndocrinologyToday.com/article/view/1-3-tsoukas.